Načítá se...
Marked response to nivolumab combined with external radiation therapy for metastatic renal cell carcinoma: report of two cases
Although nivolumab has been regarded as a standard agent for patients with previously treated advanced renal cell carcinoma (RCC), a significant proportion of these patients fail to achieve a response to nivolumab. In recent years, several studies have reported the favorable therapeutic impact of co...
Uloženo v:
| Vydáno v: | Int Cancer Conf J |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Japan
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498363/ https://ncbi.nlm.nih.gov/pubmed/31149543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-018-0349-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|